Gilead Sciences Inc (GILD)
88.85
+0.22
(+0.25%)
USD |
NASDAQ |
Nov 21, 11:06
Gilead Sciences Price: 88.85 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 88.11 | 89.08 | 87.77 | 88.63 | 4.550M |
| Nov 19, 2024 | 87.63 | 88.60 | 86.08 | 87.75 | 8.179M |
| Nov 18, 2024 | 88.38 | 89.04 | 87.63 | 88.46 | 9.100M |
| Nov 15, 2024 | 91.71 | 91.99 | 88.21 | 88.40 | 11.45M |
| Nov 14, 2024 | 92.31 | 92.66 | 91.30 | 92.11 | 8.203M |
| Nov 13, 2024 | 94.13 | 94.20 | 91.63 | 92.63 | 11.06M |
| Nov 12, 2024 | 96.35 | 96.84 | 94.22 | 94.35 | 9.323M |
| Nov 11, 2024 | 96.40 | 98.90 | 96.30 | 97.03 | 7.094M |
| Nov 08, 2024 | 96.05 | 97.32 | 94.91 | 96.56 | 7.457M |
| Nov 07, 2024 | 94.00 | 98.32 | 93.51 | 97.90 | 14.39M |
| Nov 06, 2024 | 91.00 | 91.98 | 90.50 | 91.69 | 8.819M |
| Nov 05, 2024 | 89.64 | 90.39 | 89.01 | 90.22 | 3.960M |
| Nov 04, 2024 | 89.49 | 90.71 | 89.37 | 89.84 | 6.124M |
| Nov 01, 2024 | 88.31 | 89.57 | 88.19 | 89.51 | 6.486M |
| Oct 31, 2024 | 87.94 | 89.28 | 87.74 | 88.82 | 5.895M |
| Oct 30, 2024 | 87.90 | 88.37 | 87.48 | 88.29 | 5.847M |
| Oct 29, 2024 | 88.38 | 88.52 | 86.81 | 88.08 | 6.656M |
| Oct 28, 2024 | 89.24 | 89.42 | 88.52 | 88.76 | 5.962M |
| Oct 25, 2024 | 89.45 | 89.74 | 88.45 | 89.00 | 5.735M |
| Oct 24, 2024 | 87.72 | 89.22 | 87.62 | 88.78 | 7.184M |
| Oct 23, 2024 | 88.15 | 88.39 | 87.14 | 87.23 | 4.373M |
| Oct 22, 2024 | 85.68 | 88.36 | 85.60 | 88.16 | 6.044M |
| Oct 21, 2024 | 86.64 | 87.27 | 85.92 | 86.29 | 4.451M |
| Oct 18, 2024 | 86.79 | 87.17 | 86.01 | 86.72 | 4.365M |
| Oct 17, 2024 | 86.92 | 87.65 | 86.59 | 87.36 | 4.286M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
56.65
Minimum
Dec 30 2020
97.90
Maximum
Nov 07 2024
71.52
Average
69.97
Median
Sep 28 2021
Price Benchmarks
| Eli Lilly and Co | 740.78 |
| Merck & Co Inc | 98.08 |
| Pfizer Inc | 24.90 |
| Vertex Pharmaceuticals Inc | 448.41 |
| Amgen Inc | 288.07 |
Price Related Metrics
| PE Ratio | 987.22 |
| PS Ratio | 3.930 |
| Price to Book Value | 5.994 |
| Price to Free Cash Flow | 11.79 |
| Earnings Yield | 0.10% |
| Market Cap | 110.73B |
| Operating PE Ratio | 14.56 |
| Normalized PE Ratio | 19.83 |